• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019 年欧盟(EU-27)的健康状况:2019 年全球疾病负担研究的系统分析。

The state of health in the European Union (EU-27) in 2019: a systematic analysis for the Global Burden of Disease study 2019.

机构信息

MEDCIDS, Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.

CINTESIS@RISE, Faculty of Medicine of the University of Porto, 4200-450, Porto, Portugal.

出版信息

BMC Public Health. 2024 May 22;24(1):1374. doi: 10.1186/s12889-024-18529-3.

DOI:10.1186/s12889-024-18529-3
PMID:38778362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11110444/
Abstract

BACKGROUND

The European Union (EU) faces many health-related challenges. Burden of diseases information and the resulting trends over time are essential for health planning. This paper reports estimates of disease burden in the EU and individual 27 EU countries in 2019, and compares them with those in 2010.

METHODS

We used the Global Burden of Disease 2019 study estimates and 95% uncertainty intervals for the whole EU and each country to evaluate age-standardised death, years of life lost (YLLs), years lived with disability (YLDs) and disability-adjusted life years (DALYs) rates for Level 2 causes, as well as life expectancy and healthy life expectancy (HALE).

RESULTS

In 2019, the age-standardised death and DALY rates in the EU were 465.8 deaths and 20,251.0 DALYs per 100,000 inhabitants, respectively. Between 2010 and 2019, there were significant decreases in age-standardised death and YLL rates across EU countries. However, YLD rates remained mainly unchanged. The largest decreases in age-standardised DALY rates were observed for "HIV/AIDS and sexually transmitted diseases" and "transport injuries" (each -19%). "Diabetes and kidney diseases" showed a significant increase for age-standardised DALY rates across the EU (3.5%). In addition, "mental disorders" showed an increasing age-standardised YLL rate (14.5%).

CONCLUSIONS

There was a clear trend towards improvement in the overall health status of the EU but with differences between countries. EU health policymakers need to address the burden of diseases, paying specific attention to causes such as mental disorders. There are many opportunities for mutual learning among otherwise similar countries with different patterns of disease.

摘要

背景

欧盟面临着许多与健康相关的挑战。疾病负担信息及其随时间变化的趋势对于健康规划至关重要。本文报告了欧盟和 27 个欧盟国家 2019 年的疾病负担估计值,并将其与 2010 年的估计值进行了比较。

方法

我们使用 2019 年全球疾病负担研究的估计值和 95%的不确定性区间,对整个欧盟和每个国家进行评估,以评估二级病因的标准化死亡率、生命损失年(YLLs)、残疾生活年(YLDs)和残疾调整生命年(DALYs)率,以及预期寿命和健康期望寿命(HALE)。

结果

2019 年,欧盟的标准化死亡率和 DALY 率分别为每 10 万人 465.8 人死亡和 20251.0 DALY。2010 年至 2019 年期间,欧盟各国的标准化死亡率和 YLL 率均显著下降。然而,YLD 率基本保持不变。标准化 DALY 率下降最大的是“艾滋病毒/艾滋病和性传播疾病”和“交通伤害”(各下降 19%)。“糖尿病和肾脏疾病”在整个欧盟的标准化 DALY 率显著上升(3.5%)。此外,“精神障碍”的标准化 YLL 率呈上升趋势(14.5%)。

结论

欧盟的整体健康状况明显呈改善趋势,但各国之间存在差异。欧盟卫生政策制定者需要解决疾病负担问题,特别关注精神障碍等疾病。对于疾病模式不同的相似国家,有许多相互学习的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5496/11110444/3369f3bff78b/12889_2024_18529_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5496/11110444/781208c7b1ad/12889_2024_18529_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5496/11110444/2ef445f0e399/12889_2024_18529_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5496/11110444/3369f3bff78b/12889_2024_18529_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5496/11110444/781208c7b1ad/12889_2024_18529_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5496/11110444/2ef445f0e399/12889_2024_18529_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5496/11110444/3369f3bff78b/12889_2024_18529_Fig3_HTML.jpg

相似文献

1
The state of health in the European Union (EU-27) in 2019: a systematic analysis for the Global Burden of Disease study 2019.2019 年欧盟(EU-27)的健康状况:2019 年全球疾病负担研究的系统分析。
BMC Public Health. 2024 May 22;24(1):1374. doi: 10.1186/s12889-024-18529-3.
2
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
3
The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.1990 - 2021年美国各州疾病、伤害及风险因素负担:《2021年全球疾病负担研究》的系统分析
Lancet. 2024 Dec 7;404(10469):2314-2340. doi: 10.1016/S0140-6736(24)01446-6.
4
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.1990 - 2013年全球、区域和国家306种疾病和损伤的伤残调整生命年(DALYs)以及188个国家的健康预期寿命(HALE):量化流行病学转变
Lancet. 2015 Nov 28;386(10009):2145-91. doi: 10.1016/S0140-6736(15)61340-X. Epub 2015 Aug 28.
5
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、地区和国家残疾调整生命年(DALYs)359 种疾病和伤害以及 195 个国家和地区 1990-2017 年的健康期望寿命(HALE):2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1859-1922. doi: 10.1016/S0140-6736(18)32335-3.
6
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.1990 - 2015年全球、区域和国家315种疾病和损伤的伤残调整生命年(DALYs)及健康预期寿命(HALE):全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1603-1658. doi: 10.1016/S0140-6736(16)31460-X.
7
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.204 个国家和地区 2022-2050 年疾病负担情景:2021 年全球疾病负担研究的预测分析。
Lancet. 2024 May 18;403(10440):2204-2256. doi: 10.1016/S0140-6736(24)00685-8.
8
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
9
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、地区和国家残疾调整生命年(DALYs)用于 333 种疾病和伤害以及 195 个国家和地区的健康期望寿命(HALE),1990-2016 年:全球疾病负担研究 2016 年的系统分析。
Lancet. 2017 Sep 16;390(10100):1260-1344. doi: 10.1016/S0140-6736(17)32130-X.
10
Trends in the global, regional, and national burden of oral conditions from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021.1990年至2021年全球、区域和国家口腔疾病负担趋势:全球疾病负担研究2021的系统分析
Lancet. 2025 Mar 15;405(10482):897-910. doi: 10.1016/S0140-6736(24)02811-3. Epub 2025 Feb 27.

引用本文的文献

1
Healthspan-lifespan gap differs in magnitude and disease contribution across world regions.健康寿命与寿命之间的差距在世界各地区的大小和对疾病的影响方面存在差异。
Commun Med (Lond). 2025 Sep 1;5(1):381. doi: 10.1038/s43856-025-01111-2.
2
A review of psychedelics trials completed in depression, informed by European regulatory perspectives.从欧洲监管角度对已完成的抑郁症迷幻剂试验进行的综述。
Neurosci Appl. 2025 Feb 26;4:105516. doi: 10.1016/j.nsa.2025.105516. eCollection 2025.
3
Procyanidins as potential anticancer agents: mechanisms of action, bioavailability challenges and therapeutic opportunities.

本文引用的文献

1
Cardiovascular diseases and health inequalities in Europe-a pressing public health challenge.欧洲的心血管疾病与健康不平等——一项紧迫的公共卫生挑战。
Lancet Reg Health Eur. 2023 Oct 4;33:100722. doi: 10.1016/j.lanepe.2023.100722. eCollection 2023 Oct.
2
Burden of disease among older adults in Europe-trends in mortality and disability, 1990-2019.欧洲老年人的疾病负担——1990 至 2019 年的死亡率和失能趋势。
Eur J Public Health. 2023 Feb 3;33(1):121-126. doi: 10.1093/eurpub/ckac160.
3
The burden of mental health-related mortality in the Baltic States in 2007-2018.
原花青素作为潜在的抗癌药物:作用机制、生物利用度挑战及治疗机遇
Med Oncol. 2025 Jun 11;42(7):251. doi: 10.1007/s12032-025-02814-1.
4
Pterostilbene as a Multifaceted Anticancer Agent: Molecular Mechanisms, Therapeutic Potential and Future Directions.紫檀芪作为一种多面性抗癌剂:分子机制、治疗潜力及未来方向
Med Oncol. 2025 May 24;42(7):220. doi: 10.1007/s12032-025-02721-5.
5
Mental health status of the European population and its determinants: A cross-national comparison study.欧洲人口的心理健康状况及其决定因素:一项跨国比较研究。
Eur Psychiatry. 2025 Apr 24;68(1):e103. doi: 10.1192/j.eurpsy.2025.2449.
6
The role of purpose in life in healthy aging: implications for the Semmelweis Study and the Semmelweis-EUniWell Workplace Health Promotion Model Program.生活目标在健康老龄化中的作用:对塞梅尔维斯研究及塞梅尔维斯 - 欧洲大学健康工作场所促进模式项目的启示
Geroscience. 2025 Mar 29. doi: 10.1007/s11357-025-01625-6.
7
Revolutionizing cancer treatment: the rise of personalized immunotherapies.变革癌症治疗:个性化免疫疗法的兴起
Discov Oncol. 2024 Dec 18;15(1):756. doi: 10.1007/s12672-024-01638-1.
8
Current mechanistic insights into Withaferin A: a promising potential adjuvant anticancer agent from Withania somnifera.Withaferin A的当前机制见解:一种来自睡茄的有前景的潜在辅助抗癌剂。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):3573-3593. doi: 10.1007/s00210-024-03662-y. Epub 2024 Nov 30.
9
Flavopiridol: a promising cyclin-dependent kinase inhibitor in cancer treatment.黄酮哌啶醇:一种在癌症治疗中颇具前景的细胞周期蛋白依赖性激酶抑制剂。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):3489-3511. doi: 10.1007/s00210-024-03599-2. Epub 2024 Nov 26.
10
Material and social deprivation associated with public health actual causes of death among older people in Europe: longitudinal and multilevel results from the Survey of Health, Ageing and Retirement in Europe (SHARE).物质和社会剥夺与欧洲老年人公共卫生实际死亡原因相关:来自欧洲健康、衰老和退休调查(SHARE)的纵向和多层次结果。
Front Public Health. 2024 Oct 29;12:1469203. doi: 10.3389/fpubh.2024.1469203. eCollection 2024.
2007-2018 年波罗的海国家与心理健康相关的死亡负担。
BMC Public Health. 2022 Sep 19;22(1):1776. doi: 10.1186/s12889-022-14175-9.
4
Burden of All Cancers Along With Attributable Risk Factors in China From 1990 to 2019: Comparison With Japan, European Union, and USA.1990 年至 2019 年中国所有癌症负担及归因风险因素:与日本、欧盟和美国的比较。
Front Public Health. 2022 May 26;10:862165. doi: 10.3389/fpubh.2022.862165. eCollection 2022.
5
The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990-2019: Findings from the Global Burden of Disease Study 2019.1990 - 2019年欧洲年轻人的精神障碍、物质使用障碍和自我伤害负担:全球疾病负担研究2019的结果
Lancet Reg Health Eur. 2022 Apr 1;16:100341. doi: 10.1016/j.lanepe.2022.100341. eCollection 2022 May.
6
Socio-economic inequality of utilization of cancer testing in Europe: A cross-sectional study.欧洲癌症检测利用的社会经济不平等:一项横断面研究。
Prev Med Rep. 2022 Feb 8;26:101733. doi: 10.1016/j.pmedr.2022.101733. eCollection 2022 Apr.
7
Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic.2020 年 COVID-19 大流行期间 204 个国家和地区的抑郁和焦虑障碍的全球患病率和负担。
Lancet. 2021 Nov 6;398(10312):1700-1712. doi: 10.1016/S0140-6736(21)02143-7. Epub 2021 Oct 8.
8
The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers.2020 年欧洲癌症负担:40 个国家和 25 种主要癌症的发病率和死亡率估计。
Eur J Cancer. 2021 Nov;157:308-347. doi: 10.1016/j.ejca.2021.07.039. Epub 2021 Sep 21.
9
6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.236379 例 COVID-19 幸存者的 6 个月神经和精神结局:使用电子健康记录的回顾性队列研究。
Lancet Psychiatry. 2021 May;8(5):416-427. doi: 10.1016/S2215-0366(21)00084-5. Epub 2021 Apr 6.
10
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 87 种风险因素的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2.